The top 20 by weight are MAPT, CA3, CES1, CES2 and MOAB, etc. These targets have been reported to be related to liver diseases and may play a crucial role in the therapeutic effects of WLP in treating liver cirrhosis. The gene discussed is MAPT; the disease is cirrhosis of liver.